Home

EDWARD R ARQUILLA

CIK 1200095 · last filed 2009-10-19

EDWARD R ARQUILLA is a corporate insider who has filed 7 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing, for RPC, was dated Oct 19, 2009. Across all open-market trades the lifetime net is +$2.6K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $480.2K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$480.2K

Companies

2

Total Filings

7

Lifetime Open-Market Net

$2.6K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
RPC Director 56,494 $8.50 $480.2K $0 2 2009-10-19
RADIENT PHARMACEUTICALS Corp (ADL) Delisted Director 56,494 — — $2.6K 5 2009-01-09

Recent Filings

7 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2009-10-19 RPC Grant (A) — $0 EDGAR
2009-10-19 RPC Grant (A) — $0 EDGAR
2009-01-09 RADIENT PHARMACEUTICALS Corp (ADL) Delisted Grant (A) +40,000 $28.8K EDGAR
2008-07-16 RADIENT PHARMACEUTICALS Corp (ADL) Delisted Buy (P) +1,000 $2.6K EDGAR
2008-03-31 RADIENT PHARMACEUTICALS Corp (ADL) Delisted Grant (A) — $0 EDGAR
2007-07-02 RADIENT PHARMACEUTICALS Corp (ADL) Delisted Exer (M) +13,000 $31.2K EDGAR
2007-06-11 RADIENT PHARMACEUTICALS Corp (ADL) Delisted Grant (A) — $0 EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.